Підписатись
Henning Reis, MD
Henning Reis, MD
Inst. of Pathology, University Hospital Frankfurt
Підтверджена електронна адреса в uk-essen.de
Назва
Посилання
Посилання
Рік
Activation of the ERK and AKT signalling pathway predicts poor prognosis in hepatocellular carcinoma and ERK activation in cancer tissue is associated with hepatitis C virus …
KJ Schmitz, J Wohlschlaeger, H Lang, GC Sotiropoulos, M Malago, ...
Journal of hepatology 48 (1), 83-90, 2008
3692008
Prognostic value of tissue and circulating levels of IMP3 in prostate cancer
T Szarvas, S Tschirdewahn, C Niedworok, G Kramer, S Sevcenco, H Reis, ...
International journal of cancer 135 (7), 1596-1604, 2014
1732014
Clinical, prognostic, and therapeutic aspects of urachal carcinoma—a comprehensive review with meta-analysis of 1,010 cases
T Szarvas, O Módos, C Niedworok, H Reis, A Szendröi, MA Szász, ...
Urologic Oncology: Seminars and Original Investigations 34 (9), 388-398, 2016
1642016
Thoracic staging in lung cancer: prospective comparison of 18F-FDG PET/MR imaging and 18F-FDG PET/CT
P Heusch, C Buchbender, J Köhler, F Nensa, T Gauler, B Gomez, H Reis, ...
Journal of Nuclear Medicine 55 (3), 373-378, 2014
1242014
Tumor markers as a diagnostic key for hilar cholangiocarcinoma
B Juntermanns, S Radunz, M Heuer, S Hertel, H Reis, JP Neuhaus, ...
European Journal of Medical Research 15, 357-361, 2010
1032010
Toll-like receptor 4 variant D299G induces features of neoplastic progression in Caco-2 intestinal cells and is associated with advanced human colon cancer
A Eyking, B Ey, M Rünzi, AI Roig, H Reis, KW Schmid, G Gerken, ...
Gastroenterology 141 (6), 2154-2165, 2011
1022011
AKT and ERK1/2 signaling in intrahepatic cholangiocarcinoma
KJ Schmitz, H Lang, J Wohlschlaeger, GC Sotiropoulos, H Reis, ...
World journal of gastroenterology: WJG 13 (48), 6470, 2007
962007
SF3B1 and BAP1 mutations in blue nevus-like melanoma
KG Griewank, H Müller, LA Jackett, M Emberger, I Möller, ...
Modern Pathology 30 (7), 928-939, 2017
902017
MiR-205 and MiR-373 are associated with aggressive human mucinous colorectal cancer
A Eyking, H Reis, M Frank, G Gerken, KW Schmid, E Cario
PloS one 11 (6), e0156871, 2016
772016
NF1 mutations in conjunctival melanoma
SL Scholz, I Cosgarea, D Süßkind, R Murali, I Möller, H Reis, ...
British Journal of Cancer 118 (9), 1243-1247, 2018
752018
Diagnostic accuracy of whole-body PET/MRI and whole-body PET/CT for TNM staging in oncology
P Heusch, F Nensa, B Schaarschmidt, R Sivanesapillai, K Beiderwellen, ...
European journal of nuclear medicine and molecular imaging 42, 42-48, 2015
742015
Identification of novel biomarker candidates for the immunohistochemical diagnosis of cholangiocellular carcinoma
J Padden, DA Megger, T Bracht, H Reis, M Ahrens, M Kohl, M Eisenacher, ...
Molecular & Cellular Proteomics 13 (10), 2661-2672, 2014
742014
MET expression in advanced non–small-cell lung cancer: effect on clinical outcomes of chemotherapy, targeted therapy, and immunotherapy
H Reis, M Metzenmacher, M Goetz, N Savvidou, K Darwiche, C Aigner, ...
Clinical lung cancer 19 (4), e441-e463, 2018
732018
PD-L1 expression in urothelial carcinoma with predominant or pure variant histology: concordance among 3 commonly used and commercially available antibodies
H Reis, R Serrette, J Posada, V Lu, Y Chen, A Gopalan, SW Fine, ...
The American journal of surgical pathology 43 (7), 920-927, 2019
692019
Cytomegalovirus reactivation in patients with refractory checkpoint inhibitor-induced colitis
C Franklin, I Rooms, M Fiedler, H Reis, L Milsch, S Herz, E Livingstone, ...
European Journal of Cancer 86, 248-256, 2017
672017
Impact of RAS mutation subtype on clinical outcome—a cross-entity comparison of patients with advanced non-small cell lung cancer and colorectal cancer
M Wiesweg, S Kasper, K Worm, T Herold, H Reis, L Sara, ...
Oncogene 38 (16), 2953-2966, 2019
662019
High prevalence of concomitant oncogene mutations in prospectively identified patients with ROS1-positive metastatic lung cancer
M Wiesweg, WEE Eberhardt, H Reis, S Ting, N Savvidou, C Skiba, ...
Journal of Thoracic Oncology 12 (1), 54-64, 2017
662017
Enhanced stromal syndecan-1 expression is an independent risk factor for poor survival in bladder cancer
T Szarvas, H Reis, G Kramer, SF Shariat, F Vom Dorp, S Tschirdewahn, ...
Human pathology 45 (4), 674-682, 2014
652014
Inhibitory role of the small leucine-rich proteoglycan biglycan in bladder cancer
C Niedworok, K Röck, I Kretschmer, T Freudenberger, N Nagy, T Szarvas, ...
PloS one 8 (11), e80084, 2013
622013
Biomarkers in urachal cancer and adenocarcinomas in the bladder: a comprehensive review supplemented by own data
H Reis, U Krafft, C Niedworok, O Módos, T Herold, M Behrendt, ...
Disease markers 2018, 2018
552018
У даний момент система не може виконати операцію. Спробуйте пізніше.
Статті 1–20